Mr. James Van Staveren reports

GLOW ANNOUNCES NON-BROKERED PRIVATE PLACEMENT

Glow Lifetech Corp. has arranged a non-brokered private placement financing is for gross proceeds of up to $750,000 through the issuance of up to 25 million units in the capital of the company at a price of three cents per unit. Each unit shall comprise one common share in the capital of the company and one common share purchase warrant. Each warrant entitles the holder thereof to acquire one common share at a price of five cents per common share for a period of 18 months from the date of issuance. The company intends to use the gross proceeds from the offering for general working capital purposes.

Closing of the offering is subject to receipt of all necessary corporate and regulatory approvals, including the approval of Canadian Securities Exchange. All securities issued in connection with the offering will be subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation.

About Glow Lifetech Corp.

Glow Lifetech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow has rights to the groundbreaking, plant-based MyCell Technology delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of the valuable compounds.

We seek Safe Harbor.